CorMedix Inc.
CRMD
$6.39
$0.020.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 128.62M | 104.28M | 39.74M | 39.08M | 31.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 128.62M | 104.28M | 39.74M | 39.08M | 31.21M |
| Cost of Revenue | 11.17M | 7.57M | 1.86M | 1.60M | 1.12M |
| Gross Profit | 117.45M | 96.71M | 37.87M | 37.48M | 30.09M |
| SG&A Expenses | 29.38M | 36.64M | 15.89M | 14.17M | 15.37M |
| Depreciation & Amortization | 10.14M | 3.63M | -- | -- | 52.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.29M | 52.93M | 20.19M | 18.96M | 18.27M |
| Operating Income | 69.33M | 51.35M | 19.54M | 20.13M | 12.94M |
| Income Before Tax | 56.45M | 52.58M | 20.35M | 20.64M | 13.46M |
| Income Tax Expenses | 42.43M | -55.99M | 521.50K | -- | -200.00 |
| Earnings from Continuing Operations | 14.02M | 108.56M | 19.83M | 20.64M | 13.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.02M | 108.56M | 19.83M | 20.64M | 13.46M |
| EBIT | 69.33M | 51.35M | 19.54M | 20.13M | 12.94M |
| EBITDA | 79.76M | 55.14M | 19.71M | 20.29M | 13.07M |
| EPS Basic | 0.17 | 1.43 | 0.29 | 0.32 | 0.22 |
| Normalized Basic EPS | 0.54 | 0.43 | 0.19 | 0.20 | 0.14 |
| EPS Diluted | 0.16 | 1.26 | 0.28 | 0.30 | 0.22 |
| Normalized Diluted EPS | 0.46 | 0.38 | 0.18 | 0.19 | 0.14 |
| Average Basic Shares Outstanding | 78.84M | 75.93M | 67.93M | 65.24M | 61.51M |
| Average Diluted Shares Outstanding | 93.92M | 86.21M | 71.92M | 68.98M | 61.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |